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Abstract
Objective The development of morphological and functional
imaging techniques has improved the diagnosis of muscular
disorders.
Methods With the use of whole-body magnetic resonance
imaging (MRI) the possibility of imaging the entire body
has been introduced. In patients with suspected myositis,
oedematous and inflammatory changed muscles can be
sufficiently depicted and therefore biopsies become more
precise.
Results Functional MR methods visualise different aspects
of muscular (patho)physiology: muscular sodium (Na
+)
homeostasis can be monitored with
23Na MRI; the




23Na MRI has reached
an acceptable value in the diagnosis and follow-up of
patients with muscular Na
+ channelopathies that are
characterised by myocellular Na
+ overload and consecutive
muscle weakness. Besides MRI, low mechanical index
contrast-enhanced ultrasound (CEUS) methods have also
been introduced. For evaluation of myositis, CEUS is more
efficient in the diagnostic work-up than usual b-mode
ultrasound, because CEUS can detect the inflammatory-
induced muscular hyperperfusion in acute myositis. More-
over, the arterial perfusion reserve in peripheral arterial
disease can be adequately examined using CEUS.
Conclusion Modern muscular imaging techniques offer
deeper insights in muscular (patho)physiology than just
illustrating unspecific myopathic manifestations like




Various causes, like neurogenic, metabolic, dystrophic or
inflammatory mechanisms, as well as muscular channelo-
pathies leading to disorders of the muscle cell membrane,
may potentially cause muscular diseases. Although muscu-
lar diseases are a heterogeneous group, in most cases of
progressive disease, the result is a focal or general muscular
weakness. Unfortunately, muscular weakness is a very
unspecific symptom that often does not allow conclusions
to be drawn about the origin of the paresis. Standard
neuromuscular literature suggests that radiological imaging
w o u l dp l a yo n l ya ni n f e r i o rr o l eb e c a u s eo fa b s e n t
pathognomonic findings [1]. Why does radiological imaging
hold such a low significance in the case of muscular
diseases? Routine protocols of magnetic resonance imaging
(MRI) only show morphology and demonstrate oedematous
or lipomatous changes, atrophy or hypertrophy (Fig. 1).
However, these morphological changes are not very
disease-specific [2–6]. Apparent changes like consecutive
muscular haematoma after blunt trauma can be nicely
verified, but the huge and heterogeneous group of
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DOI 10.1007/s13244-011-0111-6myopathies based upon different origins cannot be further
differentiated because the underlying (patho)physiology is
not demonstrated. The following short review introduces
examples of modern functional imaging methods for the
evaluation of muscular diseases with emphasis on patho-
physiological fundamentals.
Whole-body MRI
Whole-body MRI allows the entire human body to be
investigated within one single examination. It is necessary for
the patient to be completely covered with coils (Fig. 2a). The
examination lasts up to approximately 60 min, but the
duration depends on the protocol and sequence design used;
for example, turbo-spin-echo and gradient echo sequences
require comparatively less time than spin-echo sequences. For
the diagnosis of muscular disorders, axial and coronal T1-
weighted sequences as well as axial and coronal short-tau
inversion recovery (STIR) sequences are useful (Fig. 2b, c).
Contrast media are not needed in most cases. One of the main
advantages of whole-body MRI in the field of muscular
disorders is biopsy targeting: when a biopsy is planned,
adequate targets can regularly be found using MRI as
oedematous muscular changes, e.g. in suspected dermatositis
or polymyositis [7] .T h ed i s e a s e sh a v et ob ed i a g n o s e d
quickly, because they can be treated successfully with
immunosuppressive therapy, contrary to many other muscular
diseases. Unfortunately, they lead to irreversible muscular
weakness when the diagnosis is missed. A central problem is
that the muscles may be affected focally, and false-negative
biopsy findings are found in up to 25% in random biopsies
instead of image guidance. Common findings in MRI of an
active inflammatory process are oedematous changes of the
muscular tissue that can be—more reliably than with clinical
examination or electromyography—identified and mapped
using whole-body MRI [8, 9]. With a combination of fat-
suppressed T2-weighted sequences and T1-weighted
sequences, fatty degenerated muscular tissue can be nicely
differentiated from oedematous affected muscular tissue as
a hint for acute inflammation. These muscle regions
showing oedematous changes, which are potentially
caused by inflammation, should be targeted. Therefore,
biopsy results will be improved when performing biopsy
with imaging guidance.
However, the pathological changes of muscular tissue are
less specific. For example, rhabdomyolysis, muscular dystro-
phy or acute neuromuscular denervation may appear with
muscular oedematous changes, too. Generally, oedematous
changes give a hint for an acute process, whereas lipomatous
degeneration is observed in chronic stages of disease.
Another advantage of whole-body MRI is its potential to
show patterns of muscle involvement that are in favour of a
specific myopathy. Also, better than with clinical examina-
tion, e.g. by using the Medical Research Council (MRC)
score for paresis, subtle involvement of muscle groups can
be detected [10].
For several forms of cancer, whole-body MRI is
regularly used for the detection or control of metastases.
For example, in patients with multiple myeloma, metastases
involving connective tissue or muscle can regularly be
identified (Fig. 3)
23Na MRI
Conventional MRI uses the gyration of protons (
1H),
basically of water and carbohydrate compounds, for image
acquisition. Innovative techniques like
23Na MRI offer the
possibility of detecting sodium ions (Na
+). In a healthy
muscle cell, the Na/K-ATPase moves Na
+ out of the
cytoplasm and K
+ into the cytoplasm and thus contributes
to maintaining a constant membrane potential and an Na
+
concentration gradient. In healthy tissue, the extracellular
sodium concentration ([Na+]ex=145 mM) is about tenfold
higher than the intracellular concentration ([Na+]in=10–
15 mM) [11].
23Na MRI allows volume- and relaxation-
weighted measurements of these Na
+ compartments, non-
Fig. 1 Typical pathological changes in muscular tissue shown in standard proton (
1H) MRI
610 Insights Imaging (2011) 2:609–619invasively. The membrane potential is necessary to allow
for a contraction of muscle cells. Muscular Na
+ channels
within the cell membrane provide auxiliary control of Na
+
homeostasis. In several groups of muscle diseases, the
muscular sodium channelopathies, patients are affected
from an incomplete inactivation of these muscular Na
+
channels. The resulting Na
+ leak leads to an inward Na
+
current that causes an ongoing depolarisation of muscle
fibres and an increase in the intracellular Na
+ concentration.
This leads to an elevated total Na
+ concentration compared
with healthy muscle tissue.
23Na MRI is able to non-
invasively measure this pathological increase in the Na
+
concentration. However,
23Na MRI is associated with
several challenges. First, the physical NMR sensitivity of
23Na is only about 9% of the sensitivity of
1H. Considering
a 1,000- to 5,000-fold lower in vivo concentration
compared with
1H, this leads to an 11,000- to 55,000-fold
lower
23Na signal. Second, the
23Na signal in vivo decays
bi-exponentially, with a fast (0.5–3.0 ms) and a slow (15–
30 ms) component. To measure the total
23Na signal,
sequences with ultra-short echo times are necessary [12].
Furthermore, acquisition techniques that combine both
short echo times and high signal-to-noise ratio efficiency,
such as twisted projection imaging [13] or density-adapted
sampling [14] are favourable for
23Na MRI. Moreover,
specific hardware and software are needed; for example,
double resonant coils that are able to work with the
resonance frequency both of sodium nuclei (16.8 MHz at
1.5 Tesla; 78.6 MHz at 7 Tesla) and protons (63.6 MHz at
1.5 Tesla; 300 MHz at 7 Tesla). It is a further challenge to
discriminate between the intracellular and extracellular
amount of sodium via non-invasive techniques like MRI.
Fig. 2 a Example of a completely covered patient during a whole-
body MRI examination. b Whole-body MRI of a 67-year-old patient
with sarcoidosis-associated chronic myositis. The arrow clearly shows
oedematous changes within the enlarged image of the left fibularis
muscle using fat-saturated sequences. c Whole-body MRI of the same
patient as in b: standard T1-weighted sequences clearly show
lipomatous changes. The arrow within the enlarged image indicates
lipomatous degeneration of the right semimembranosus muscle
Insights Imaging (2011) 2:609–619 611Paramagnetic shift reagents allow for a clear separation
between intracellular and extracellular sodium [15]. Unfor-
tunately, they cannot be applied in humans because of their
toxicity. Current research in
23Na MRI demonstrated the
possibility of reducing the signal from extracellular sodium
compartments, such as in vasogenic oedema. A
23Na
inversion recovery sequence was developed to reduce the
23Na signal received from vasogenic oedema to achieve a
weighting of the intracellular
23Na amount [16].
23Na MRI
has effectively achieved value in the radiological manage-
ment of muscular sodium channel diseases [17, 18]. In the
affected patients, an autosomal-dominant bequeathed defect
of muscular Na
+ channels leads to a pathological Na
+ influx
that causes intermittent or permanent muscular paresis as
well as muscular stiffness (Fig. 4a)[ 19]. Typical triggers are
exposure to cold or ingestion of potassium-rich food. The
diseases appear rarely, examples would be hyperkalaemic
and hypokalaemic periodic paralysis or paramyotonia
congenita.
23Na MRI is able to depict an intracellular
muscular sodium accumulation simultaneous to development
of muscular paresis or muscular stiffness (Fig. 4b). The
sodium accumulation correlates well with the grade of
paresis and is reproducible [18, 20]. Additionally,
23Na
MRI allows for therapy monitoring; for example, mexiletine
reduces myoplasmic sodium overload in patients with
paramyotonia congenita. With
23Na MRI, the decrease in
myoplasmic Na
+ content becomes visible non-invasively.
Another example is hypokalaemic periodic paralysis that
goes along with intramuscular Na
+ accumulation. The
sodium overload causes muscle oedema and weakness in
these patients, and it now can be treated specifically with
acetazolamide [17]. The muscular oedema as well as the
muscular weakness will decrease under treatment, and the
muscular strength will improve. Recently, the development
of
23Na MRI at field strengths of 3–7 Tesla (standard are 1.5-
Tesla devices) allows for a more precise quantification of
intracellular
23Na homeostasis. In addition,
23Na homeostasis
may be examined more precisely in healthy volunteers as
well as in patients, because initial findings indicate the high
potential of
23Na MRI at 7 Tesla (Fig. 5)[ 21].
31P-magnetic resonance spectroscopy
31P-magnetic resonance (MR) spectroscopy was introduced
in the 1980s with the aim of evaluating the energy
metabolism of muscular tissue. The phosphorous MR
spectrum demonstrates several peaks of specific energy
metabolites, like phosphocreatine, that mirrors a typical
short-time energy deliverer, as well as anorganic phosphate
that is a degradation product [22]. Moreover, adenosine-5′-
triphosphate, which is necessary for muscular contraction,
as well as phosphodiester, can be extrapolated from the
spectrum and quantified (Fig. 6a). When the chemical shift
of anorganic phosphate to phosphocreatine is analysed, the
intracellular pH value can be calculated. These techniques
can be used successfully in vivo during muscular exercise
and can depict a decrease in phosphocreatine during
physical trials [23]. The technique offers a useful diagnostic
tool; for example, in patients suffering from the glycogenosis
McArdle’s disease, the muscular glycolysis is disturbed, and
Fig. 3 Whole-body MRI of a
45-year-old patient with multi-
ple myeloma. The STIR
sequence clearly shows a bone
metastasis located in the left
os ilium and the perifocal
muscular reaction depicted as
oedematous changes
612 Insights Imaging (2011) 2:609–619the physiological decrease of pH value due to lactate
production does not take place. This can reliably be
demonstrated in patients with glycogenosis/McArdle’sd i s -
ease using
31P-MR spectroscopy [24, 25]. Several research
groups tried to find a specific pattern using
31P-MR
spectroscopy, but the muscular degeneration finally leads to
lipomatous conversion and consecutive loss of high-energy
phosphates within the spectrum that can finally be observed
in all chronic myopathies. Moreover, the cross-sectional area
of muscular fibres correlates with the amount of phospho-
creatine and adenosine-5′-triphosphate. This correlation
makes sense, as both metabolites are necessary for muscular
contraction. Further developed
31P-MR spectroscopy-related
imaging techniques allow for a spatial illustration of the
phosphocreatine signal received and thus a two-dimensional
illustration of the muscular energy level [26].
Proton (
1H) MR spectroscopy
This method delivers the opportunity to quantify intra-
myocellular lipids [27]. Further interesting metabolites are
phosphocreatine, choline as a marker for the rebuilding of
the cell membrane, or extramyocellular lipids that are
present within the lipomatous intermuscular connection
tissue and the subcutis and are regarded as a contaminator
of the intramyocellular lipids in a spectrum (Fig. 6b). But
intramyocellular lipids show a highly inter-individual
variability and it is obvious that different physical con-
ditions of muscles obtain different concentrations of this
lipid fraction. Therefore, it sounds a paradox that athletes
show a high level of intramyocellular lipids and a high
insulin sensitiveness of their muscular tissue. However, the
intramyocellular lipids serve as energy donators for the
Fig. 4 a In muscular sodium channel diseases, a defective sodium
channel within the muscular cell membrane leads to a pathological
influx of Na
+ after provocation with typical triggers, e.g. exposition to
cold. Results are muscular weakness or muscular stiffness. b STIR
weighted
1H imaging shows elevated signal in the lower leg muscles
of this patient suffering from hypokalaemic periodic paralysis type 1.
The intracellular Na
+ accumulation can be visualised nicely with
23Na
(arrows). Observe the reference tubes: 0.3% NaCl solution in the
middle, 0.3% NaCl bound with agarose gel on the left-hand side, 0.6%
NaCl solution on the right-hand side
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in intramyocellular lipids. Interestingly, untrained patients
suffering from type-2 diabetes with peripheral muscular
insulin resistance show a high level of intramyocellular
lipids too [28, 29]. In the end, many parameters influence
the level of intramyocellular lipids, e.g. dietary nutrition,
sex, gender, body mass index and the oxygen content of
tissue. Additionally, modern spectroscopic techniques deliver
the possibility of spatially visualising the evaluated resonance
peaks with the aid of parametric colour maps. Several groups
are researching
13C-MR spectroscopy. The nucleus plays an
important part in muscle physiology and pathophysiology
[30, 31]. A central problem is that the MRI need special
equipment like broadband transmitters and receivers to allow
for
13C-MR spectroscopy. Nevertheless, a further develop-
ment of this technique may be expected in the future.
Blood oxygen level-dependent MRI
Blood oxygen level-dependent (BOLD) MRI mirrors the
local ratio of oxyhaemoglobin and deoxyhaemoglobin.
T2*-weighted functional MRI sequences are in common
use for BOLD MRI. The signal acquisition is based upon
susceptibility effects and subsequent MRI signal changes in
muscular tissue, caused by the paramagnetic effect of
deoxyhaemoglobin. Oxyhaemoglobin, in turn, is diamagnetic.
For muscular tissue, in particular, the signal is influenced by
themicrovasculardensity,bloodflowandvolume,andoxygen
extraction rate [32–36]. Experiments evaluating the BOLD
response of muscular tissue during post-occlusive reactive
hyperaemia showed a steep increase in the T2* signal,
followed by a non-linear signal decrease. In patients with
peripheral arterial disease (PAD), the T2* signal increase
during post-occlusive reactive hyperaemia is a lesser step and
delayed. Moreover, a significant age-dependent difference in
the rate, intensity and recovery of the post-occlusive muscle
BOLD signal was revealed [37, 38].
Arterial spin labelling MRI
Arterial spin labelling (ASL) is based upon magnetic
labelling of moving blood particles of a certain slice by
an inversion pulse at the first step, and read-out of the
labelled blood particles during arrival in the slice of interest
(for example, the capillary bed) at the second step [39].
Before acquisition of the image with labelled blood
Fig. 5
23Na MRI at 3 T
(TE=0.2 ms) and 7 T (TE=
0.55 ms). Transverse and
coronal slices of the lower legs
in a healthy volunteer. Observe
the significantly improved
signal-to-noise ratio at 7 T
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blood particles is acquired and serves as a control. The
difference between the labelled and the control image yield
the perfusion-weighted image (Fig. 7). The received
signal increases linearly proportional to the underlying
tissue perfusion [40, 41]. An advantage is the illustration
of local perfusion without the need for contrast media. A
disadvantage is the comparatively long examination time.
The technique has reached a level of clinical acceptance
for quantification of muscular perfusion with MRI [39,
41]. Moreover, the development of arterial spin labelling
techniques at ultra-high field MRI showed that the signal-
to-noise ratio and thus image quality is enhanced with an
increase in field strength [42]—which will additionally
improve the frequency of clinical implementation.
MR elastography
With MR elastography (MRE) a quantitative measure of
mechanical elasticity of tissue and muscles is possible. The
technique allows for visualisation of disturbed fibre
characteristics due to pathological changes within the
tissue. For example, cancer, inflammation and fibrosis
may change the local tissue elasticity. Image acquisition
obtains several steps. First, shear waves within the
examined tissue are generated. Second, the propagation
of the induced waves is depicted with MRI. Third, a
postprocessing of the depicted shear wave images is
performed and quantitative maps of tissue elasticity are
produced. For skeletal muscle, several approaches in
MRE exist. For example, MRE showed that neuromus-
cular diseases (i.e. childhood poliomyelitis, spastic and
flaccid paraplegia) have an influence on muscle elasticity
[43]. Moreover, MRE can be used for quantification of
muscle stiffness caused by immobilisation [44] and thus
has the potential to visualise effects of rehabilitation in
patients with loss of mobility. In conclusion, MRE delivers
important information about the local or general fibre
physiology and pathology; it can be predicted that MRE
will reach a higher level of clinical acceptance in the
future.
Diffusion-weighted imaging and diffusion tensor imaging
With diffusion-weighted imaging (DWI) the mobility of
water molecules (and therefore the mobility of
1H protons)
can be visualised. The fundamental hypothesis is that the
mobility of water molecules within diseased tissue (for
example, cancer-involved or inflammatory tissue) differs
from that of normal tissue. For image acquisition, the spins
of
1H protons are activated and the resulting echo is
recorded. In diseased tissue with decreased ability of
diffusion, the activated
1H protons obtain decreased
mobility and thus remain at almost the same place. The
result is a high intensity of regions with disturbed diffusion
on DWI images. The potential of DWI for brain and stroke
Fig. 6 Typical metabolites in the muscular
31phosphorous MR
spectrum (a) and muscular
1H-MR spectrum (b)
Insights Imaging (2011) 2:609–619 615imaging has already been well demonstrated [45–47].
Diffusion tensor imaging (DTI) is a further development
of DWI, where the direction of diffusion is captured. As a
benefit, tractographies, for example, of neuronal structures
like nerve fibres, can be reconstructed. Development of
DWI and DTI for examination of the musculoskeletal
system is still just beginning, but the first results are
promising [48, 49]. Physiological and impaired muscle
function can be sufficiently examined by using diffusion
tensor imaging. As DTI values are related to the state of
muscle contraction, the technique allows for a non-invasive
measure of muscle elasticity and its capability of contrac-
tion [50]. A precise quantification of muscular DTI seems
to be reproducible even in different individuals, as age or
gender has no effect on water diffusivity values [51]. With
an emphasis on in vivo MR tractography, the anatomical
structure and micro-architecture of muscle fibres can be
visualised [52]. DTI offers the opportunity to qualitatively
determine the impacting force vectors. For example, in
patients with lateral patellar dislocation, the visualisation of
force vectors delivers important information about the static
and dynamic constitution of the knee joint [53]. Not only
muscles, but also nerves are visualised by functional MRI.
Recent research in neuro-imaging attested DTI to be an
excellent tool for detecting injuries or entrapments of
peripheral nerves and their recovery after trauma [54].
The deranged and recovered micro-architecture of the
peripheral nerves itself becomes visible, whereas conven-
tional sequences like STIR only provide secondary infor-
mation, such as consecutive oedema.
Real-time ultrasound elastography
With ultrasound elastography, the relative tissue rigidness
can be visualised. Therefore, the technique allows for a
more objective quantification of the findings gained from
conventional palpation by the physician. Analogous to the
duplex ultrasound, the colour-coded map that mirrors the
tissue rigidness is overlaid on the B-mode ultrasound
image. The performance of ultrasound elastography for
detection of suspicious breast lesions, pancreatic lesions or
suspicious lymphatic nodules had been approved before
[55–57]. In the case of muscular diseases, ultrasound
elastography delivers additional information about the local
condition of the muscle, because the local muscle rigidness
may be disturbed in several muscular diseases. Moreover,
Fig. 7 Description of arterial spin labelling. Previously inverted magnetisation enters the slice of interest and is exchanged with normal tissue
magnetisation. The resulting image intensity is a measure of local tissue perfusion
616 Insights Imaging (2011) 2:609–619the technique can be used to localise parts of diseased
muscle and thus alleviate muscle biopsies.
Contrast-enhanced ultrasound (CEUS)
Usually, B-mode ultrasound is the first practiced and the
most frequently used examination to evaluate muscular
disorders. The outcome of sports accidents like ruptures of
muscular fibres, haematomas, ruptures of ligaments or
extrusion can be well demonstrated [58]. The development
of ultrasound over the last few years has made it possible to
visualise (patho)physiological information about muscular
microcirculation. Ultrasound contrast media are stabilised
microbubbles that stay within the vasculature and thus can
be used to evaluate the capillary muscular perfusion.
Ultrasound contrast media of the first generation
consist of microbubbles that are burst with the use of
high-energy ultrasound pulses. During the burst, an
ultrasound signal is emitted, a so-called stimulated
acoustic emission (SAE), and can be received. A
disadvantage of first-generation ultrasound contrast media
was that an evaluation of local perfusion in real time was
not possible. For example, examination during muscular
exercise could not be performed.
Second-generationultrasoundcontrastmedialikeSonoVue
(Bracco Imaging, Milan, Italy) are not destroyed by ultra-
sound waves but are put into oscillation. Using this technique,
increased muscular tissue perfusion in correlation with an
increased number of capillaries can be evaluated in real time.
For example, endurance-trained athletes obtain an increased
muscular tissue perfusion during rest in combination with a
high density of capillaries compared with non-trained volun-
teers. Moreover, the quantified local blood volume within the
selected ultrasound slice correlates with the aerobic capacity
and with the perfusion evaluated with venous occlusion
plethysmography [59]. Also, changes in the micro-
Fig. 8 Examples of typical
signal-intensity-over-time
curves of the dynamic CEUS
examination. a A rapid increase
in the measured CEUS signal
was observed after release of
arterial occlusion in a healthy
volunteer, while the time–
intensity curve of a patient with
peripheral arterial disease
(walking distance, 100 m)
increased more slowly with a
delayed and less high maximum
after provocation (b)
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become visible in real time [60]. This information allows for
a better understanding of the physiological adaption of
skeletal muscle due to physical strain or inflammation, and
has the potential to improve exercise testing and prescription.
In the case of confirmed dermatomyositis or polymyositis, a
significantly higher muscular perfusion compared with
healthy volunteers was shown [61]. Additionally, the
oedematous muscular changes visible in B-mode ultrasound
underline the suspicion of acute myositis. In the case of
confirmed polymyositis, immunosuppressive therapy causes
an increased muscular strength, a reduction in the creatinine
kinase level and decreased muscular perfusion at rest.
Special ultrasound techniques allow for the detection of
oscillating microbubbles, separation from muscular tissue
and deliver the opportunity to assess muscular tissue
perfusion in real time. Depending on the grade of isometric
physical exercise, reduced perfusion due to compression of
muscular venules can be observed. At the end of physical
exercise, an increased ultrasound signal can be detected
because of reactive hyperperfusion. These findings showed
that the resulting hyperperfusion depended on the grade of
muscular exercise [59]. Moreover, the arterial perfusion
reserve can be adequately examined with CEUS in
combination with transient arterial occlusion. Initial find-
ings showed that the arterial perfusion reserve in patients
suffering from PAD is reduced in comparison to that of
healthy volunteers (Fig. 8). Further prospective studies are
required to evaluate if this technique is sufficient for use in
monitoring pro-angiogenic therapy in patients with PAD.
Conclusion
Muscular diseases and their pathological features are
complex. Ultrasound and MRI allow for much more than
a simple evaluation of lipomatous, oedematous, hypertro-
phic or hypotrophic changes within muscular tissue.
Pathophysiological surrogate parameters such as muscular
microcirculation, sodium homeostasis, energy and lipid
metabolism or muscular tissue elasticity can be examined.
We expect a much higher level of acceptance of these new
techniques in the near future.
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